Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26170,3457,1.14 [1.07-1.21],2.384764463898036e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26399,2852,1.11 [1.03-1.18],0.003386489468125
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,26734,1366,1.16 [1.06-1.28],0.0018004905080841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25172,805,1.21 [1.07-1.37],0.0023431974183335
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24355,947,1.19 [1.06-1.33],0.0029203633097998
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18968,1663,1.16 [1.06-1.26],0.00094293611042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26953,1585,1.15 [1.06-1.26],0.0016288404640183
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27023,887,1.21 [1.07-1.36],0.0016576243561742
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26915,779,1.21 [1.06-1.37],0.0032275274729003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25494,126,1.55 [1.17-2.05],0.002416225610932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Descending colon,27121,154,0.65 [0.47-0.89],0.0069175199884683
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Carcinoma in situ of breast,22008,134,0.58 [0.41-0.81],0.0017696883721028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22075,32,2.34 [1.56-3.51],3.827657703925971e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,22081,38,2.17 [1.43-3.29],0.0002539429258372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22194,151,1.54 [1.19-2.00],0.0009764036206153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22135,92,1.75 [1.28-2.40],0.0004294081500788
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26541,69,1.70 [1.17-2.47],0.0057480075342299
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26135,2935,1.17 [1.10-1.25],2.044669596078658e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,26739,48,2.19 [1.52-3.16],2.760805597670145e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26557,1517,1.18 [1.08-1.29],0.0003821294510021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26557,1517,1.18 [1.08-1.29],0.0003821294510021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26733,1259,1.23 [1.12-1.36],3.0207780471855435e-05
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25718,64,1.92 [1.25-2.95],0.0029058869991949
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24692,3130,1.16 [1.09-1.24],2.83962437720325e-06
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,26849,177,1.43 [1.11-1.83],0.0048207473005797
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26256,2308,1.11 [1.03-1.19],0.0075743097762523
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21774,212,1.48 [1.18-1.86],0.0006819294038152
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26236,4674,1.15 [1.09-1.21],1.2707478974186554e-07
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21824,262,1.40 [1.14-1.72],0.0012464770195929
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26655,1467,1.28 [1.17-1.40],1.123713614272179e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,25609,865,1.25 [1.11-1.40],0.000225120134587
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiac arrest,16299,128,1.66 [1.26-2.19],0.0003391543883067
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26231,1497,1.20 [1.09-1.31],9.360431797087932e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24376,7174,1.11 [1.06-1.15],2.146439710291744e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,24997,6078,1.11 [1.06-1.16],1.2567587475329598e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25009,6090,1.11 [1.06-1.16],9.71714879870559e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19021,102,1.71 [1.24-2.35],0.0011059545008243
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26418,1674,1.21 [1.11-1.31],1.429926499157433e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27113,85,1.58 [1.13-2.20],0.0077444517347266
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26512,197,1.40 [1.11-1.78],0.0051456032244396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,26525,4275,1.09 [1.03-1.15],0.0015054957409518
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,26728,1188,1.23 [1.11-1.37],9.058160326464509e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23618,1368,1.18 [1.07-1.30],0.0007321240001401
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25077,5100,1.10 [1.05-1.16],0.000140642538433
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Emphysema,23353,269,1.36 [1.11-1.67],0.0034854560683013
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",24774,78,1.76 [1.25-2.49],0.001189582123551
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",26711,78,1.75 [1.24-2.46],0.0015220377531274
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23709,684,1.22 [1.07-1.39],0.003270090652305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23192,167,1.41 [1.10-1.83],0.0078493696870096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18552,222,1.48 [1.19-1.84],0.0004017776898112
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27125,219,1.50 [1.20-1.87],0.0003729468217827
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26070,1240,1.25 [1.14-1.38],6.595058848692365e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26307,1477,1.21 [1.10-1.32],6.324639353551983e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,26962,79,1.73 [1.23-2.45],0.0017428297383355
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26944,2443,1.16 [1.08-1.24],6.521338134749987e-05
